| Telena Mullins, FNP-BC | |
|
26108 Lee Hwy, Abingdon, VA 24211-7502 | |
| (276) 477-4600 | |
| (423) 491-8109 |
| Full Name | Telena Mullins |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 6 Years |
| Location | 26108 Lee Hwy, Abingdon, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457846040 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wythe County Community Hospital | Wytheville, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Emergency Coverage Services Pc | 8820983430 | 45 |
News Archive
Amakem NV, a kinase platform company focusing on ophthalmology, today announces that it has initiated a Phase 2a proof of concept study of its novel Rho Kinase (ROCK) inhibitor, AMA0076, in patients with glaucoma and ocular hypertension.
Many of the nation's physicians are now involved in the effort to eliminate racial and ethnic health care disparities, according to a recent survey released by the Commission to End Health Care Disparities.
Black Death or plague that killed an estimated one-third of Europe's population in the Middle Ages has been ascribed to a bacteria called Yersinia pestis by anthropologists.
The Senate Finance Committee met Wednesday to discuss potential funding mechanisms for health reform legislation but indicated that no concrete decisions had been reached, The Hill reports.
› Verified 8 days ago
| Entity Name | Blue Ridge Medical Management Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326159567 PECOS PAC ID: 9739099441 Enrollment ID: O20040715001336 |
News Archive
Amakem NV, a kinase platform company focusing on ophthalmology, today announces that it has initiated a Phase 2a proof of concept study of its novel Rho Kinase (ROCK) inhibitor, AMA0076, in patients with glaucoma and ocular hypertension.
Many of the nation's physicians are now involved in the effort to eliminate racial and ethnic health care disparities, according to a recent survey released by the Commission to End Health Care Disparities.
Black Death or plague that killed an estimated one-third of Europe's population in the Middle Ages has been ascribed to a bacteria called Yersinia pestis by anthropologists.
The Senate Finance Committee met Wednesday to discuss potential funding mechanisms for health reform legislation but indicated that no concrete decisions had been reached, The Hill reports.
› Verified 8 days ago
| Entity Name | Emergency Coverage Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053351593 PECOS PAC ID: 8820983430 Enrollment ID: O20061003000679 |
News Archive
Amakem NV, a kinase platform company focusing on ophthalmology, today announces that it has initiated a Phase 2a proof of concept study of its novel Rho Kinase (ROCK) inhibitor, AMA0076, in patients with glaucoma and ocular hypertension.
Many of the nation's physicians are now involved in the effort to eliminate racial and ethnic health care disparities, according to a recent survey released by the Commission to End Health Care Disparities.
Black Death or plague that killed an estimated one-third of Europe's population in the Middle Ages has been ascribed to a bacteria called Yersinia pestis by anthropologists.
The Senate Finance Committee met Wednesday to discuss potential funding mechanisms for health reform legislation but indicated that no concrete decisions had been reached, The Hill reports.
› Verified 8 days ago
| Entity Name | Legacy Vein Center Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477972933 PECOS PAC ID: 2264727627 Enrollment ID: O20200515000961 |
News Archive
Amakem NV, a kinase platform company focusing on ophthalmology, today announces that it has initiated a Phase 2a proof of concept study of its novel Rho Kinase (ROCK) inhibitor, AMA0076, in patients with glaucoma and ocular hypertension.
Many of the nation's physicians are now involved in the effort to eliminate racial and ethnic health care disparities, according to a recent survey released by the Commission to End Health Care Disparities.
Black Death or plague that killed an estimated one-third of Europe's population in the Middle Ages has been ascribed to a bacteria called Yersinia pestis by anthropologists.
The Senate Finance Committee met Wednesday to discuss potential funding mechanisms for health reform legislation but indicated that no concrete decisions had been reached, The Hill reports.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Telena Mullins, FNP-BC 26108 Lee Hwy, Abingdon, VA 24211-7502 Ph: (276) 477-4600 | Telena Mullins, FNP-BC 26108 Lee Hwy, Abingdon, VA 24211-7502 Ph: (276) 477-4600 |
News Archive
Amakem NV, a kinase platform company focusing on ophthalmology, today announces that it has initiated a Phase 2a proof of concept study of its novel Rho Kinase (ROCK) inhibitor, AMA0076, in patients with glaucoma and ocular hypertension.
Many of the nation's physicians are now involved in the effort to eliminate racial and ethnic health care disparities, according to a recent survey released by the Commission to End Health Care Disparities.
Black Death or plague that killed an estimated one-third of Europe's population in the Middle Ages has been ascribed to a bacteria called Yersinia pestis by anthropologists.
The Senate Finance Committee met Wednesday to discuss potential funding mechanisms for health reform legislation but indicated that no concrete decisions had been reached, The Hill reports.
› Verified 8 days ago
Chesley Stanley, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 607 Campus Dr, Abingdon, VA 24210 Phone: 276-525-4603 | |
Matthew J Sykes, ANP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 300 East Valley Street, Abingdon, VA 24210 Phone: 276-628-7600 Fax: 276-628-2629 | |
Dr. Courtney Neel Rogers, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 16000 Johnston Memorial Dr Ste 213, Abingdon, VA 24211 Phone: 276-258-2600 | |
Virginia A. Thurston, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 613 Campus Dr, Suite 200, Abingdon, VA 24210 Phone: 276-628-1186 Fax: 276-628-8507 | |
Rebekah Christine Davis, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 631 Campus Dr, Abingdon, VA 24210 Phone: 276-676-3870 Fax: 276-628-8927 | |
Mrs. Lora Diane Reynolds, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 16000 Johnston Memorial Dr, Suite 313, Abingdon, VA 24211 Phone: 276-258-3780 Fax: 276-258-3776 | |
Dr. Diana Michelle Oakes, DNP FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 16000 Johnston Memorial Dr Ste 312c, Abingdon, VA 24211 Phone: 276-258-1000 |